Treating acute myeloid leukemia (AML) depends on knowing what goes wrong inside cells. A new study suggests that two genetic ...
Incyte said on Monday its experimental combo therapy helped patients with a type of blood cancer live longer without their ...
Based on phase 3 trial data, the FDA accepted an sBLA for nivolumab plus AVD for untreated stage III or IV classical Hodgkin lymphoma.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback